ClinConnect ClinConnect Logo
Search / Trial NCT01628302

Effect of Salt Restriction on Renin Activation

Launched by TURKISH SOCIETY OF HYPERTENSION AND RENAL DISEASES · Jun 22, 2012

Trial Information

Current as of August 02, 2025

Completed

Keywords

Hypertension,Plasma Renin Activity,Salt Consumption

ClinConnect Summary

The present study is carried out with the subjects who are chosen among the nursing home residents in İzmir. The subjects were randomized to 2 groups and while one of these groups had low salt diet (50mmol), the other group had normal salt diet (250mmol) for 3 weeks. Subjects had normal salt diet in their daily routine life for the following 2 weeks. According to crossover nature of the study, the group that had normal salt diet at the first 3 weeks of study had low salt diet at the last 3 weeks of the study. The other group that had low salt diet had the normal salt diet at the last 3 week...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Subjects who are 50 years and older
  • Subjects whose systolic blood pressure is ≥ 140 mmHg
  • Subjects whose diastolic blood pressure is ≥ 90 mmHg
  • Subjects who is normal weighted defined as body mass index \< 25 or who is obese defined as body mass index \> 30
  • Subjects who have intellectual capacity to adapt diets and 24 hour urine collection
  • Informed about the study and consented to include the study
  • Exclusion Criteria:
  • Known heart failure
  • Known renal failure
  • Known chronic liver disease
  • Antihypertensive drug use
  • nonsteroidal anti inflammatory (NSAI) drug use

About Turkish Society Of Hypertension And Renal Diseases

The Turkish Society of Hypertension and Renal Diseases is a leading clinical trial sponsor dedicated to advancing research and improving patient outcomes in the fields of hypertension and renal health. Comprising a network of experts, healthcare professionals, and researchers, the Society fosters innovative studies that address critical challenges in cardiovascular and renal medicine. Through collaborative efforts and evidence-based practices, the Society aims to enhance clinical guidelines, promote awareness, and contribute to the development of effective therapeutic interventions, ultimately improving the quality of care for patients with hypertension and renal disorders in Turkey and beyond.

Locations

Patients applied

0 patients applied

Trial Officials

Mustafa Arici, Prof.

Principal Investigator

Hacettepe University Faculty of Medicine Department of Nephrology

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials